Tumor Activated Cell Penetrating Peptides to Selectively Deliver Immune Modulatory Drugs

Recent advances in immunotherapy have revolutionized cancer therapy. Immunotherapies can engage the adaptive and innate arms of the immune system. Therapeutics targeting immune checkpoint inhibitors (i.e., CTLA-4; PD-1, and PD-L1) have shown efficacy for subsets of cancer patients by unleashing an a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hingorani, Dina V., Camargo, Maria F., Quraishi, Maryam A., Adams, Stephen R., Advani, Sunil J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000974/
https://www.ncbi.nlm.nih.gov/pubmed/33801967
http://dx.doi.org/10.3390/pharmaceutics13030365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000974/
https://www.ncbi.nlm.nih.gov/pubmed/33801967
http://dx.doi.org/10.3390/pharmaceutics13030365

Ejemplares similares